Saliva test reveals smoking and gum disease worsen cell damage
NCT ID NCT07279896
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether smoking and severe gum disease (Stage III periodontitis) increase damage to DNA and RNA in cells. Researchers measured two markers of oxidative stress in saliva from 88 adults, including smokers and non-smokers with and without gum disease. They found that people with gum disease had higher damage levels, and smokers with gum disease had the highest. The findings suggest a simple saliva test could help detect gum disease and show how smoking adds to cell stress.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
88 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consisted of systemically healthy adults aged 18-65 years, including individuals with Stage III periodontitis and periodontally healthy controls. Participants were categorized into four groups based on periodontal status and smoking habits: smokers and non-smokers with Stage III periodontitis, and smokers and non-smokers who were periodontally healthy.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals aged 18 years or older * Having at least 16 permanent teeth, excluding third molars * Not using orthodontic appliances * Not pregnant or breastfeeding * Systemically healthy individuals with no systemic diseases that could affect periodontal status * No use of anti-inflammatory or antimicrobial medications within the last 6 months * No periodontal treatment within the last 12 months Exclusion Criteria: * Pregnant or breastfeeding individuals. * Use of anti-inflammatory or antimicrobial drugs in the past 6 months. * Use of antioxidant supplements in the past 3 months. * Periodontal treatment within the past 12 months. * Diagnosis of psychiatric disorders. * Any oral infection. * Fewer than 16 permanent teeth (excluding third molars). * Alcohol dependence. * Active infectious diseases (Acute hepatitis, AIDS, tuberculosis), malignancy, or any systemic condition that may affect periodontal tissues. * Current use of medications known to affect periodontal tissues (phenytoin, cyclosporine A, calcium channel blockers).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontitis (stage 3) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara University Faculty of Dentistry, Department of Periodontology
Ankara, Yenimahalle, 06560, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Gum fluid proteins eyed as link between smoking and periodontitis
- Magnifying the fight against gum disease: loupe vs microscope
- Can laser or Air-Polishing boost gum disease treatment?
- Can a Skin-Derived graft match the gold standard for saving molars?
- Which wound dressing best protects knee replacements?